Kefir & Yakult

By Michelangelo Flayed

The children and young people of our planet, thanks to high immune defenses, have avoided the infection with COVID-19.

They are not alone.

Japan with 120 million inhabitants had less contaminated than Switzerland, eight million,
and a few dozen dead.

Without political prejudices their daily life habits were explored,
to know the collective conduct of this people,
so different in culture, religion and traditions from ours,
but that allowed them to raise their immune barriers,
indispensable requirement to limit the pandemic of the third millennium.

Identifying their habits to modulate them on our daily behaviors is not difficult.

They lead to salvation!
 

• Language: English
• Publisher: Branca & Breda
• Release date: May 21, 2020
• ISBN: 9788835830566

Book preview

Ringraziamenti

COVID-19

A new coronavirus, called severe acute respiratory syndrome coronavirus 2, SARS-CoV-2, has been identified as the cause of an outbreak of respiratory disease first detected in Wuhan, China in 2019, the disease caused by this virus. it was called coronavirus disease 2019, COVID-19.

The Centers for Disease Control and Prevention revealed the ultrastructural morphology exhibited by coronaviruses.

Seen electronically under a microscope, the peaks that adorn the external surface of the virus can be seen, giving the appearance of a crown surrounding the virion.

Since February 17, 2020, the epidemichas spread to all the DISTRICTS of mainland China and, turning into a pandemic, it has spread rapidly to almost all countries in the world.

After only a month and a half, at the end of March, the million infections were exceeded.

In response to this health emergency, an interactive online dashboard, hosted by the Center for Systems Science and Engineering at Johns Hopkins University in Baltimore, USA, was developed to view and track reported cases of COVID-19 in real time.

The dashboard, shared for the first time on January 22, illustrates the location and number of confirmed cases, deaths and healings for all countries in the world.

All data collected and displayed are made available for free on a website.

As the epidemic evolved, the manual reporting process became unsustainable, which is why a semi-automated living data flow strategy was adopted.

All updates are coordinated by the John Hopkins University team.

CONTRAST ACTIONS

The best teams of doctors and scientists from the five continents are engaged 24 hours a day in the search for a vaccine that can defeat the virus. In addition to financing them, each state makes available any element useful for the construction of the vaccine.

While waiting for FINAL, existing drugs are tested in the hope that they can interrupt the course of the disease.

The European Medicines Agency, Ema, is working to find an antidote capable of eliminating the pandemic: 20 new drugs and 35 vaccines would be under evaluation.

300 people are working at the agency 24 hours a day to test all possible medicines.

According to reports from the executive director of the agency, we learn of a summit between Ema, the US FDA and Icmra, the International Coalition that brings together 17 medicines regulatory authorities.

The priority is to find immediate treatment while continuing to work on the vaccine non-stop.

On the immediate care front, potential antiviral and potential new drugs are being evaluated.

The hope is to have the widest possible and homogeneous clinical tests for the whole European Union.

The Italian AIFA has started the clinical trial of Remdesivir, a drug developed as a treatment for the disease

Ebola virus and Marburg virus infections by Gilead Sciences.

Aifa and the National Institute for the Study and Treatment of Cancer in Naples have also launched a study to evaluate the efficacy and safety of the active ingredient Tocilizumab in the treatment of Covid-19.

Tocilizumab was approved in 2010 in the United States for rheumatoid arthritis.

Aifa’s ok in testing Avigan, a Japanese coronavirus drug, announced the Minister of Health.

There are 9 vaccine candidates for the treatment of the virus in China.

Here the scientists are collaborating with a military team led by Major General Chen Wei, an epidemiologist and virologist at the Academy of Military Medical Sciences.

Then there are American companies.

Several times there has been speeches and discussions about tests launched by Moderna, which sent the vaccine compound to the National Institute for Allergies and Infectious Diseases, Niaid which started phase 1 of the clinical trial on people.

At work also Medicago, a Canadian biopharmaceutical company based in the city of Quebec, which in a note released by the company, successfully produced a Coronavirus Virus-Like Particle in just 20 days from obtaining the SARS-CoV-2 gene .

Experts from Israel's Migal Research Institute, an applied research organization specializing in the fields of biotechnology, environmental sciences and agriculture, founded in 1979 in the city of Kiryat Shmona, is starting with an infectious bronchitis virus vaccine, a strain of Coronavirus that affects poultry to develop the Covid-19 vaccine.

The Russian Federal Health and Consumer Rights Service has announced the start of vaccine tests to prevent and control the Covid-19 epidemic.

The state research center of Virology and Biotechnology Vector, which belongs to the Rospotrebnadzor, has